terlipressin has been researched along with Systemic Inflammatory Response Syndrome in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bajaj, JS; Boyer, TD; Escalante, S; Jamil, K; Pappas, SC; Sanyal, AJ; Wong, F | 1 |
Hofbeck, M; Kumpf, M; Michel, J; Neunhoeffer, F; Renk, H; Spiller, G | 1 |
Bone, HG; Ertmer, C; Sielenkämper, AW; van Aken, H; Westphal, M | 1 |
Traber, DL; Westphal, M | 1 |
Araújo, LV; Freitas, GG; Martins, GA; Salluh, JI; Santino, MS; Verdeal, JC | 1 |
1 review(s) available for terlipressin and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
[Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function].
Topics: Animals; Humans; Lypressin; Microcirculation; Oxygen Consumption; Sepsis; Systemic Inflammatory Response Syndrome; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2005 |
1 trial(s) available for terlipressin and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome.
Topics: Aged; Canada; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Placebos; Retrospective Studies; Survival Analysis; Systemic Inflammatory Response Syndrome; Terlipressin; Treatment Outcome; United States; Vasoconstrictor Agents | 2017 |
3 other study(ies) available for terlipressin and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Safety and Efficacy of Terlipressin in Pediatric Distributive Shock: A Retrospective Analysis in 20 Children.
Topics: Adolescent; Catecholamines; Child; Child, Preschool; Female; Heart Rate; Hemodynamics; Humans; Hypotension; Infant; Infant, Newborn; Lypressin; Male; Retrospective Studies; Shock; Systemic Inflammatory Response Syndrome; Terlipressin; Treatment Failure; Vasoconstrictor Agents; Young Adult | 2017 |
Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art?
Topics: Animals; Hemodynamics; Humans; Liver Circulation; Lypressin; Sepsis; Splanchnic Circulation; Systemic Inflammatory Response Syndrome; Terlipressin; Vasoconstrictor Agents | 2005 |
Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury.
Topics: Accidents, Traffic; Adolescent; Blood Pressure; Brain Injuries; Catecholamines; Cerebrovascular Circulation; Drug Resistance; Fatal Outcome; Humans; Lypressin; Male; Motorcycles; Multiple Organ Failure; Norepinephrine; Oxygen; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Systemic Inflammatory Response Syndrome; Terlipressin; Time Factors; Vasoconstrictor Agents | 2007 |